Company intelligence
Alfasigma USA, Inc.
About Alfasigma USA, Inc.
Alfasigma is a global pharmaceutical company founded over 75 years ago in Italy, where it is headquartered (in Bologna and Milan). The Group operates in over 100 markets spanning Europe, North and South America, Asia, and Africa. It has offices in many countries, including Italy, the US, Spain, Germany, Mexico, and China; production sites in Italy (Pomezia, RM; Alanno, PE; Sermoneta, LT; Trezzano Rosa, MI), Spain (Tortosa, Baix Ebre), and the United States (Shreveport, Louisiana); and R&D labs in Italy (Pomezia and Bergamo). Alfasigma employs approximately 4,000 people dedicated to research, development, production, and distribution of medicinal products, contributing to its mission to provide better health and a better quality of life for patients, caregivers, and healthcare providers. It focuses on three main therapeutic areas: Gastroenterology, Vascular, and Rheumatology. Its portfolio spans from primary care to specialty care, rare disease medications, and consumer health products, including medical foods and nutraceuticals. Alfasigma USA is the Nutrition business for the Alfasigma headquartered in Morristown, NJ. For more information please follow our local website below. Websites http://www.alfasigma.com https://www.alfasigmausa.com
Verified activity
Signals from Alfasigma USA, Inc.
2 published signals
Research & Knowledge
Alfasigma USA, Inc. published a new Cochrane review examining vitamin B12 supplementation in children under 12 across 10 countries with 16 trials involving over 4,000 children aged 2 to 11 years.
Reported by William Nikolic, Ph.D.
Research & Knowledge
Alfasigma USA, Inc. published a network analysis of 2,454 older adults showing that APOE ε4 carriers do not show significant connectivity or network architecture differences compared to non-carriers in a metabolic network involving homocysteine, creatinine, lipids, and vitamin D.
Reported by William Nikolic, Ph.D.